Expression of enhancer of zeste homolog 2 (EZH2) in Invasive neuroendocrine carcinoma of the breast

被引：0
|
作者：
Gong, Y. [1 ]
Chen, J. [2 ]
Radvanyi, L. [2 ]
Rosen, D. G. [1 ]
Wu, Y. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Onocl, Houston, TX 77030 USA
来源：
HISTOPATHOLOGY | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
58
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [21] Positive Expression of Enhancer of Zeste Homolog 2 (EZH2) Predicts Shorter Overall Survival in Patients with Inflammatory Breast Cancer
    Gong, Y.
    Huo, L.
    Sneige, N.
    Cristofanilli, M.
    LABORATORY INVESTIGATION, 2010, 90 : 47A - 48A
  • [22] Value of Enhancer of Zeste Homolog 2 (EZH2) for Determining Prognosis in Colon Cancer
    Gholami, Nassrin
    Sanaat, Zohreh
    Dolatkhah, Roya
    Nikanfar, Alireza
    Esfahani, Ali
    Danandehmehr, Amin
    Akhrjou, Ashraf
    Farassati, Faris
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2020, 14 (03)
  • [23] The methyltransferases enhancer of zeste homolog (EZH) 1 and EZH2 control hepatocyte homeostasis and regeneration
    Bae, Woo Kyun
    Kang, Keunsoo
    Yu, Ji Hoon
    Yoo, Kyung Hyun
    Factor, Valentina M.
    Kaji, Kosuke
    Matter, Matthias
    Thorgeirsson, Snorri
    Hennighausen, Lothar
    FASEB JOURNAL, 2015, 29 (05): : 1653 - 1662
  • [24] Immunohistochemical loss of enhancer of Zeste Homolog 2 (EZH2) protein expression correlates with EZH2 alterations and portends a worse outcome in myelodysplastic syndromes
    Sakhdari, Ali
    Class, Caleb
    Montalban-Bravo, Guillermo
    Sasaki, Koji
    Bueso-Ramos, Carlos E.
    Patel, Keyur P.
    Routbort, Mark J.
    Loghavi, Sanam
    Ok, Chi Young
    Quesada, Andres
    Khoury, Joseph D.
    Konoplev, Sergej N.
    Kantarjian, Hagop P.
    Garcia-Manero, Guillermo
    Medeiros, L. Jeffrey
    Kanagal-Shamanna, Rashmi
    MODERN PATHOLOGY, 2022, 35 (09) : 1212 - 1219
  • [25] Enhancer of Zeste Homolog 2 (EZH2) Expression Is Associated with Metastasis and Adverse Clinical Outcome in Clear Cell Renal Cell Carcinoma
    Xu, B.
    Abourbih, S.
    Sircar, K.
    Kassouf, W.
    Aprikian, A.
    Tanguay, S.
    Brimo, F.
    LABORATORY INVESTIGATION, 2013, 93 : 259A - 260A
  • [26] Enhancer of Zeste Homolog 2 (EZH2) Expression Is Associated with Metastasis and Adverse Clinical Outcome in Clear Cell Renal Cell Carcinoma
    Xu, B.
    Abourbih, S.
    Sircar, K.
    Kassouf, W.
    Aprikian, A.
    Tanguay, S.
    Brimo, F.
    MODERN PATHOLOGY, 2013, 26 : 259A - 260A
  • [27] Increased expression of enhancer of Zeste Homolog 2 (EZH2) differentiates squamous cell carcinoma from normal skin and actinic keratosis
    Xie, Qiang
    Wang, Hongbei
    Heilman, Edward R.
    Walsh, Michael G.
    Haseeb, M. A.
    Gupta, Raavi
    EUROPEAN JOURNAL OF DERMATOLOGY, 2014, 24 (01) : 41 - 45
  • [28] EZH2 expression in invasive lobular carcinoma of the breast
    SiGyun Roh
    Shin Young Park
    Hyoung Suk Ko
    Jang Sihn Sohn
    Eun Jung Cha
    World Journal of Surgical Oncology, 11
  • [29] Increased expression of enhancer of Zeste Homolog 2 (EZH2) differentiates squamous cell carcinoma from normal skin and actinic keratosis
    Qiang Xie
    Hongbei Wang
    Edward R. Heilman
    Michael G. Walsh
    M. A. Haseeb
    Raavi Gupta
    European Journal of Dermatology, 2014, 24 : 41 - 45
  • [30] EZH2 expression in invasive lobular carcinoma of the breast
    Roh, SiGyun
    Park, Shin Young
    Ko, Hyoung Suk
    Sohn, Jang Sihn
    Cha, Eun Jung
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2013, 11
12345